Relative to Tardive Dyskinesia Awareness Week.
The resolution's passage reflects a commitment to addressing the challenges faced by over 60,000 Californians estimated to suffer from TD. Increased awareness is essential for ensuring better patient outcomes and reducing stigma. The resolution emphasizes the need for healthcare providers to recognize TD, which is often misdiagnosed or unrecognized, thereby calling for regular screenings as recommended by the American Psychiatric Association. This proactive approach can lead to earlier interventions and better quality of care for those at risk of developing TD from DRBAs.
Senate Resolution No. 35, introduced by Senator Archuleta, aims to increase awareness of Tardive Dyskinesia (TD), a severe and often debilitating movement disorder caused by the long-term use of dopamine receptor blocking agents (DRBAs). The resolution declares the week of May 6, 2019, as Tardive Dyskinesia Awareness Week in California, highlighting the condition's impact on individuals suffering from serious mental illnesses, as well as those with gastrointestinal disorders treated by DRBAs. By recognizing this week, the resolution seeks to educate the public about TD, its causes, symptoms, and the importance of regular screening and evaluation for affected patients.
Overall, the sentiment surrounding SR 35 is positive, with support from both legislators and healthcare advocates who recognize the importance of raising awareness for TD. The resolution embodies a compassionate approach to mental health issues and acknowledges the challenges faced by patients and caregivers. The unanimous vote with 38 yeas and no nays indicates a collective recognition of the necessity to engage in conversations about TD and promote understanding within the healthcare community and the general public.
While SR 35 has received wide support, the main contention may arise from the ongoing challenges associated with TD management and the discussions about improving the healthcare system’s capacity to screen for and treat such conditions. The resolution does not propose any changes to existing laws or funding allocations, which could be areas of future discussion as stakeholders look for comprehensive solutions to support patients suffering from both TD and related mental health issues. The dialogue ignited by this resolution sets the stage for further legislative action focusing on treatment resources and support systems.